Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/9/2025

Medication-Induced Dry Mouth

Common Medication Classes That Cause Dry Mouth

  • Centrally acting anticholinergic drugs such as scopolamine and atropine block muscarinic receptors, causing blurring of vision, dry mouth, dilated pupils, urinary retention, and sedation, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
  • Anticholinergics used for motion sickness, like scopolamine, commonly cause xerostomia, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 1
  • Tricyclic antidepressants have significant anticholinergic effects, making them common causes of xerostomia 2
  • Bupropion causes dry mouth as a common side effect, as noted in Diabetes Care 3
  • Cyclobenzaprine has significant anticholinergic effects, with dry mouth being one of its most common adverse reactions 2
  • Stimulant medications like phentermine cause dry mouth in a significant percentage of users, according to Diabetes Care 3
  • Beta-blockers, such as atenolol, metoprolol, and propranolol, can cause dry mouth, as reported in Pediatrics 4
  • Opioids commonly cause dry mouth as one of their adverse effects 2
  • Anti-obesity medications like phentermine/topiramate and naltrexone/bupropion list dry mouth as a common side effect, as noted in Diabetes Care 3

Management Strategies

  • Optimize hydration by increasing water intake throughout the day and limiting caffeine consumption, as recommended by Praxis Medical Insights 5
  • Use saliva substitutes such as moisture-preserving mouth rinses, sprays, or gels with neutral pH, as suggested by Praxis Medical Insights 5
  • Employ salivary stimulants including sugar-free chewing gum, lozenges, or candy containing xylitol, as recommended by Praxis Medical Insights 5
  • For severe cases, systemic sialagogues such as pilocarpine may be considered, according to Praxis Medical Insights 5

Dry Mouth (Xerostomia) Management

Clinical Significance and Assessment

  • Underlying conditions such as Sjögren's syndrome or sicca syndrome can contribute to dry mouth in patients on Rinvoq (upadacitinib) 6

Management Strategies for Medication-Associated Dry Mouth

  • The National Comprehensive Cancer Network recommends dietary modifications, improved hydration, and limited caffeine intake for mild dry mouth symptoms 6
  • Topical measures including water sips, saliva substitutes, and moisture-preserving mouth rinses or sprays are recommended for mild dry mouth symptoms 6
  • Salivary stimulants such as sugarless chewing gum, lozenges, or candy can help manage mild dry mouth symptoms 6
  • Systemic sialagogues such as cevimeline or pilocarpine may be considered for moderate to severe dry mouth that significantly impacts quality of life 6
  • Dental referral is recommended to ensure adequate hygiene and protect against the risk of dental caries in patients with moderate to severe dry mouth 6

Monitoring and Follow-up

  • Regular dental check-ups are important for patients experiencing chronic dry mouth to monitor for dental caries and other oral complications 6
  • Further evaluation for underlying causes may be warranted if dry mouth persists despite management strategies and significantly impacts quality of life 6

Blood Pressure Medications and Dry Mouth Risk

Medication Classes and Dry Mouth Association

  • Centrally acting agents, such as clonidine, cause dry mouth as one of their most prevalent adverse effects through alpha-adrenergic mechanisms, according to the American Academy of Pediatrics 7
  • Beta-blockers, including atenolol, metoprolol, and propranolol, can cause dry mouth through anti-adrenergic effects, with effects more pronounced during treatment with atenolol compared to propranolol, as reported by the American Heart Association 7

Dry Mouth Related to Medication Use

Evidence for Medication-Induced Dry Mouth

  • Higher SSRI doses, such as fluoxetine, are associated with a greater frequency and severity of anticholinergic side effects, including dry mouth, according to the National Comprehensive Cancer Network 8, 9
  • The American College of Physicians and other guideline societies imply that dry mouth is a common occurrence with SSRI use, listing it among typical side effects alongside nausea, constipation, decreased appetite, and fatigue 8

Clinical Management Approach

  • The National Comprehensive Cancer Network recommends first-line conservative measures, including optimizing hydration, using topical measures like saliva substitutes, and recommending salivary stimulants like sugar-free chewing gum 10
  • Dietary modifications, such as avoiding crunchy, spicy, acidic, or hot foods/drinks, can help alleviate dry mouth symptoms 10
  • If symptoms persist, consideration of systemic sialagogues like pilocarpine or cevimeline may be necessary, as well as medication adjustment, such as reducing the fluoxetine dose while maintaining therapeutic benefit 8, 10

Important Clinical Caveats

  • The National Comprehensive Cancer Network and Clinical Gastroenterology and Hepatology guideline societies suggest avoiding premature medication discontinuation, as the benefits of fluoxetine and propranolol should be weighed against the dry mouth side effect 8, 11
  • Regular dental check-ups are essential for patients experiencing chronic dry mouth to monitor for complications like dental caries and tooth loss 10

Medication-Induced Dry Mouth: Contributing Factors and Clinical Consequences

Medication Classes and Their Effects

  • Antihistamines, analgesics, antipyretics, antibiotics, and vaccines can contribute to reduced saliva flow, affecting salivary analytes 12
  • AChE inhibitors used for Alzheimer's disease increase saliva production, while many antidepressants decrease flow 12

Additional Contributing Factors

  • Fluid intake restrictions can compound medication-induced dry mouth, and dehydration from any cause worsens the perception and severity of xerostomia 13
  • Minor salivary gland parenchymal fibrosis and atrophy can develop with chronic medication use 13

Clinical Consequences

  • Reduced saliva flow increases the risk of dental caries, oral infections, and periodontal disease 13

Diagnostic Considerations

  • Rule out other causes unrelated to medications, such as candidiasis, burning mouth syndrome, Sjögren's syndrome, or sicca syndrome 14
  • Some conditions may increase saliva in the mouth due to reduced clearance, mimicking hypersalivation despite actual reduced production 12

Population Vulnerability

  • Elderly patients are at substantially higher risk due to multiple medications and age-related decline in salivary flow rate 12

Management of Dry Mouth

Initial Assessment and Diagnosis

  • Sicca syndrome, distinct from Sjögren's syndrome, presents with abrupt onset dry mouth, usually without dry eyes, and can occur independently, according to the National Comprehensive Cancer Network 15

Stepwise Treatment Algorithm

  • Implement dietary modifications by avoiding crunchy, spicy, acidic, or hot foods that exacerbate discomfort, as recommended by the National Comprehensive Cancer Network 15
  • For patients with measurable salivary flow who fail conservative measures, consider systemic sialagogues, such as pilocarpine 5 mg orally three to four times daily, as suggested by the National Comprehensive Cancer Network 15

Essential Monitoring and Referrals

  • Refer to dentistry for all patients with moderate to severe dry mouth to ensure adequate oral hygiene and protect against dental caries, which is a significant risk with chronic xerostomia, according to the National Comprehensive Cancer Network 15
  • Consider rheumatology referral for moderate to severe cases, especially if symptoms persist despite management or if there is clinical suspicion for underlying autoimmune disease beyond what ANA testing reveals, as recommended by the National Comprehensive Cancer Network 15

Important Clinical Caveats

  • Dry mouth from sicca syndrome may show partial improvement with corticosteroids, but usually requires chronic management for salivary dysfunction, according to the National Comprehensive Cancer Network 15

Dry Mouth Causes and Diagnostic Considerations

  • Sjögren's syndrome should be highly suspected in patients with clinically significant dry eye AND dry mouth symptoms, and serological testing should include SSA, SSB, rheumatoid factor, and antinuclear antibody, with point-of-care tests including additional biomarkers such as salivary protein 1, carbonic anhydrase 6, and parotid secretory protein, according to the American Academy of Ophthalmology 16
  • Sarcoidosis can affect salivary glands, and consideration of serum lysozyme, ACE levels, and chest CT is recommended, as suggested by the American Academy of Ophthalmology 16
  • Ocular mucous membrane pemphigoid may present with dry mouth alongside ocular symptoms, and diagnostic evaluation should be guided by the American Academy of Ophthalmology 16
  • Thyroid eye disease can be associated with dry mouth, and testing for antithyroid peroxidase antibody and antithyroglobulin antibody is recommended, according to the American Academy of Ophthalmology 16

Local Oral Conditions

  • Oral candidiasis can cause burning sensations and should be ruled out as it may mimic or complicate xerostomia, with diagnosis and treatment guided by the American Dental Association 17
  • Burning mouth syndrome presents with burning of the tongue and oral mucosa with normal-appearing mucosa, predominantly in peri- and post-menopausal women, and is a disorder of peripheral nerve fibers with central brain changes, according to the British Society of Anaesthesia 17

REFERENCES

1

clinical practice guideline: ménière's disease. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

2

Cyclobenzaprine-Associated Dry Mouth [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Managing Dry Mouth Caused by Vyvanse (Lisdexamfetamine) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

nccn guidelines® insights: management of immunotherapy-related toxicities, version 2.2024. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2024

8

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

10

nccn guidelines® insights: management of immunotherapy-related toxicities, version 2.2024. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2024

15

nccn guidelines® insights: management of immunotherapy-related toxicities, version 2.2024. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2024